Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer
Abstract Lung cancer is the leading cause of death worldwide. Especially, non-small cell lung cancer (NSCLC) has higher mortality rate than the other cancers. The high mortality rate is partially due to lack of efficient biomarkers for detection, diagnosis and prognosis. To find high efficient bioma...
Guardado en:
Autores principales: | Chuantao Zhang, Man Jiang, Na Zhou, Helei Hou, Tianjun Li, Hongsheng Yu, Yuan-De Tan, Xiaochun Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9c2605b63a07471c93a57ed7106aa4f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis
por: Ke Gong MBBS, et al.
Publicado: (2021) -
Cetuximab and biomarkers in non-small-cell lung carcinoma
por: Patil N, et al.
Publicado: (2012) -
Advances in Biomarkers for Immunotherapy of Non-small Cell Lung Cancer
por: Chuan HUANG, et al.
Publicado: (2021) -
Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition
por: Lei Gao, et al.
Publicado: (2019) -
High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis
por: Shi-ang Qi, et al.
Publicado: (2021)